- 著者
- 
             
             Kazuhide Inage
             
             Takeshi Sainoh
             
             Takayuki Fujiyoshi
             
             Otagiri Takuma
             
             Yasuchika Aoki
             
             Masahiro Inoue
             
             Yawara Eguchi
             
             Sumihisa Orita
             
             Yasuhiro Shiga
             
             Masao Koda
             
             Tsutomu Akazawa
             
             Takeo Furuya
             
             Junichi Nakamura
             
             Hiroshi Takahashi
             
             Miyako Suzuki
             
             Satoshi Maki
             
             Hideyuki Kinoshita
             
             Masaki Norimoto
             
             Tomotaka Umimura
             
             Takashi Sato
             
             Masashi Sato
             
             Masahiro Suzuki
             
             Keigo Enomoto
             
             Hiromitsu Takaoka
             
             Norichika Mizuki
             
             Takashi Hozumi
             
             Ryuto Tsuchiya
             
             Geundong Kim
             
             Tomohito Mukaihata
             
             Takahisa Hishiya
             
             Seiji Ohtori
             
          
- 出版者
- The Japanese Society for Spine Surgery and Related Research
- 雑誌
- Spine Surgery and Related Research (ISSN:2432261X)
- 巻号頁・発行日
- pp.2020-0042,  (Released:2020-07-10)
- 被引用文献数
- 
             
             
             3
             
             
          
        
        Introduction: Mirogabalin should be equivalent to pregabalin, but with fewer incidences of adverse drug reactions (ADRs). To verify these benefits in actual clinical trials, our study investigated the frequency of ADRs and mirogabalin' s analgesic effects during treatment of peripheral neuropathic pain.Methods: This study included 74 patients with lower limb pain. We surveyed patient reports of ADRs during the follow-up period as the primary endpoint and examined the visual analog scale (VAS) reported for lower limb pain as the secondary endpoint (before administration, and two and four weeks after administration).Results: The occurrence of ADR was 27.0%, like the frequency of ADRs in the clinical trials for other disorders. However, the discontinuation rate of administration was 10.8%, which was significantly lower than the frequency of ADR occurrences. When the analgesic effect was assessed, a significant decrease in the temporal change of VAS for lower limb pain was observed before administration, and two and four weeks after administration.Conclusions: In this study, the occurrence of ADRs reported by the patients was like the frequency of ADRs reported in the clinical trials for other disorders. When assessing the analgesic effect, the temporal change of VAS for lower limb pain was found to decrease significantly before administration, and two and four weeks after administration.